Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

Upcoming Events

09.10.

CPHI international 2018
Madrid, Spain

20.10.

UEGW 2018
Vienna, Austria

12.11.

Medica 2018
Duesseldorf, Germany

Biohit GI Panel
Annual Report 2017
GastroPanel interpretation
Safe Helicobacter pylori diagnostics
Acetium partnering
Study Protocols

Groundbreaking Diagnostics

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”.

Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.

Study Protocols

Biohit shares study protocols, i.e., descriptions of clinical studies designed for validation of Biohit Oyj’s diagnostic tests as well as for evaluation of therapeutic efficacy of Biohit’s Acetium capsule and lozenge products in current and novel clinical indications.

Innovations

Biohit's products and services are safe, ethical and costefficient innovations for diagnosing and preventing gastrointestinal diseases and the associated risks.